FMP

FMP

Blog
Screener
Extras

IMVT - Immunovant, Inc.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a

photo-url-https://financialmodelingprep.com/image-stock/IMVT.png

Immunovant, Inc.

IMVT

NASDAQ

37.5 USD

0.37 (0.99%)

About

ceo

Dr. Peter Salzmann M.B.A., M.D.

sector

Healthcare

industry

Biotechnology

website

https://immunovant.com

exchange

NASDAQ

Description

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

CIK

0001764013

ISIN

US45258J1025

CUSIP

45258J102

Address

320 West 37th Street

Phone

917 580 3099

Country

US

Employee

164

IPO Date

Jun 21, 2019

Summary

CIK

0001764013

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

45258J102

ISIN

US45258J1025

Country

US

Price

37.5

Beta

0.74

Volume Avg.

1.54M

Market Cap

5.45B

Shares

-

52-Week

14.05-45.58

DCF

3.05

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-20.72

P/B

-

Website

https://immunovant.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest IMVT News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep